These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2947566)

  • 1. Immunologic regulator and effector functions in perimyocarditis, postmyocarditic heart muscle disease and dilated cardiomyopathy.
    Maisch B
    Basic Res Cardiol; 1986; 81 Suppl 1():217-41. PubMed ID: 2947566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunologic regulator and effector mechanisms in myocarditis and perimyocarditis.
    Maisch B
    Heart Vessels Suppl; 1985; 1():209-17. PubMed ID: 2956237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Humoral and cellular immunity in perimyocarditis and congestive cardiomyopathy].
    Maisch B; Kochsiek K
    Kardiologiia; 1985 Jun; 25(6):95-102. PubMed ID: 2995721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Four years of experience in endomyocardial biopsy--an immunohistologic approach.
    Maisch B; Büschel G; Izumi T; Eigel P; Regitz V; Deeg P; Pfeifer U; Schmaltz A; Herzum M; Liebau G
    Heart Vessels Suppl; 1985; 1():59-67. PubMed ID: 3916479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic relevance of humoral and cytotoxic immune reactions in primary and secondary dilated cardiomyopathy.
    Maisch B; Deeg P; Liebau G; Kochsiek K
    Am J Cardiol; 1983 Nov; 52(8):1072-8. PubMed ID: 6356861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Secondary immunopathogenesis of cardiac diseases].
    Maisch B
    Fortschr Med; 1984 May; 102(18):516-20. PubMed ID: 6376300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiocytolytic antimyolemmal antibodies in dilated cardiomyopathy following presentation: observations in 7 patients.
    Taha TH; Mazeika PK; Oakley CM; Maisch B
    Int J Cardiol; 1993 Feb; 38(2):133-40. PubMed ID: 8454375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic relevance of humoral and cell-mediated immune reactions in patients with acute viral myocarditis.
    Maisch B; Trostel-Soeder R; Stechemesser E; Berg PA; Kochsiek K
    Clin Exp Immunol; 1982 Jun; 48(3):533-45. PubMed ID: 6288291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic determinants in conventionally treated myocarditis and perimyocarditis--focus on antimyolemmal antibodies.
    Maisch B; Outzen H; Roth D; Hiby A; Herzum M; Hengstenberg C; Hufnagel G; Schönian U; Kochsiek K
    Eur Heart J; 1991 Aug; 12 Suppl D():81-7. PubMed ID: 1915461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytolytic anticardiac membrane antibodies in the pathogenesis of myopericarditis.
    Maisch B; Drude L; Hengstenberg C; Hufnagel G; Schönian U; Schwab D
    Postgrad Med J; 1992; 68 Suppl 1():S11-6. PubMed ID: 1409209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological cellular regulator and effector mechanisms in myocarditis.
    Maisch B; Bülowius U; Schmier K; Klopf D; Koper D; Sibelis T; Kochsiek K
    Herz; 1985 Feb; 10(1):8-14. PubMed ID: 2858443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rickettsial perimyocarditis--a follow-up study.
    Maisch B
    Heart Vessels; 1986; 2(1):55-9. PubMed ID: 3522535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surface antigens of adult heart cells and their use in diagnosis.
    Maisch B
    Basic Res Cardiol; 1985; 80 Suppl 1():47-51. PubMed ID: 2581549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Secondary immunopathogenesis in myocarditis, diseases of the heart muscles and infarct-associated arrhythmia in childhood and adulthood].
    Maisch B; Schwab D; Sandhage K; Schmaltz AA; Wimmer M
    Wien Klin Wochenschr; 1989 Jan; 101(1):31-9. PubMed ID: 2643844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological defects precursors of myocarditis and dilated cardiomyopathy?
    Bolte HD
    J Mol Cell Cardiol; 1985 Jul; 17 Suppl 2():69-71. PubMed ID: 3162035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are antisarcolemmal (ASAs) and antimyolemmal antibodies (AMLAs) "natural" antibodies?
    Maisch B; Drude L; Hengstenberg C; Herzum M; Hufnagel G; Kochsiek K; Schmaltz A; Schönian U; Schwab MD
    Basic Res Cardiol; 1991; 86 Suppl 3():101-14. PubMed ID: 1664204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytolytic cross-reactive antibodies directed against the cardiac membrane and viral proteins in coxsackievirus B3 and B4 myocarditis. Characterization and pathogenetic relevance.
    Maisch B; Bauer E; Cirsi M; Kochsiek K
    Circulation; 1993 May; 87(5 Suppl):IV49-65. PubMed ID: 8485834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiomyopathy and myocarditis--a review of new aspects in research in West Germany.
    Maisch B; Izumi T
    Heart Vessels Suppl; 1985; 1():8-13. PubMed ID: 2956241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular and molecular bases for the immunopathology of the myocardial cell damage involved in acute viral myocarditis with special reference to dilated cardiomyopathy.
    Seko Y; Yamazaki T; Shinkai Y; Yagita H; Okumura K; Naito S; Imataka K; Fujii J; Yazaki Y
    Jpn Circ J; 1992 Oct; 56(10):1062-72. PubMed ID: 1331556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of inflammatory dilated cardiomyopathy and (peri)myocarditis with immunosuppression and i.v. immunoglobulins.
    Maisch B; Hufnagel G; Kölsch S; Funck R; Richter A; Rupp H; Herzum M; Pankuweit S
    Herz; 2004 Sep; 29(6):624-36. PubMed ID: 15912438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.